Ostrum Asset Management’s Eli Lilly LLY Stock Holding History

Ostrum Asset Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$86.8M	Sell	72,402 -1,691	-2%	-$1.73M	4.18%	4
2026 Q1	$68.1M	Buy	74,093 +6,090	+9%	+$6.17M	3.83%	5
2025 Q4	$73.1M	Sell	68,003 -1,636	-2%	-$1.56M	3.51%	6
2025 Q3	$53.1M	Buy	69,639 +55,579	+395%	+$41.4M	2.39%	8
2025 Q2	$11M	Buy	14,060 +1,289	+10%	+$1M	0.51%	30
2025 Q1	$10.5M	Buy	12,771 +520	+4%	+$433K	0.56%	27
2024 Q4	$9.46M	Buy	12,251 +2,514	+26%	+$2.08M	0.82%	12
2024 Q3	$8.63M	Buy	9,737 +1,375	+16%	+$1.24M	0.71%	16
2024 Q2	$7.57M	Sell	8,362 -3,169	-27%	-$2.53M	0.66%	18
2024 Q1	$8.97M	Sell	11,531 -493	-4%	-$351K	0.71%	14
2023 Q4	$7.01M	Sell	12,024 -601	-5%	-$351K	0.61%	21
2023 Q3	$6.78M	Sell	12,625 -2,530	-17%	-$1.3M	0.63%	17
2023 Q2	$7.11M	Buy	15,155 +388	+3%	+$163K	0.6%	21
2023 Q1	$5.07M	Buy	+14,767	New	+$4.98M	0.44%	52

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ostrum Asset Management's LLY Position: Q2 2026 in Review

Ostrum Asset Management reduced its Eli Lilly (LLY) stake by 2.3% in Q2 2026, selling an estimated $1.73M and leaving 72,402 shares worth $86.8M. The position accounts for 4.18% of the portfolio, ranked #4.

Ostrum Asset Management first reported a position in LLY in Q1 2023 and has held it in 14 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Ostrum Asset Management held 72,402 shares of Eli Lilly worth $86.8M as of Q2 2026.
Ostrum Asset Management sold 1,691 Eli Lilly shares in Q2 2026, an estimated $1.73M.
Eli Lilly made up 4.18% of Ostrum Asset Management's portfolio in Q2 2026, its #4 holding.
Ostrum Asset Management first reported a position in Eli Lilly in Q1 2023 and has held it in 14 quarters since.
4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Ostrum Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.